Movantik Tablet, Film Coated
Product Images NDC 82625-8801

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Movantik (NDC 82625-8801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Valinor Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Label-30s-12.5mg (Label 30s 12 5mg)

This is a label of a pharmaceutical product named "MOVA" by Valinor Pharma, LLC with its expiry year mentioned as 2023. The label suggests keeping the product away from children and storing it at a controlled room temperature of 20-25°C (68-77°F). The exact dosage for adults is to be obtained from the package insert. The product is distributed by Valinor Pharma, LLG from Chicago, IL 60606.*

FDA Label Image

Label-30s-25mg (Label 30s 25mg)

This text seems to be a label of medication prescribed for adults with instructions on dosage, storage, and safety warnings. It recommends keeping the medicine out of the reach of children, and being stored at a temperature range of 20-25°C (68-77°F). The label has been copyrighted by a pharmaceutical company named Valinor Pharma, LLC and there is a reference to the USP controlled room. The text also features a unique identifier code, GTIN 00382625880213, and a reference to a package insert for dosage information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.